RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Results from the RE-LY Trial
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 4
SP 17
OP 20
DO 10.1177/155989770904011
UL http://mdc.sagepub.com/content/9/4/17.abstract
AB Results from the Randomized Evaluation of Long-Term Anticoagulant Therapy [RE-LY] trial showed that the oral direct thrombin inhibitor dabigatran is a safe and effective alternative to warfarin for the prevention of stroke in patients with atrial fibrillation.